116 related articles for article (PubMed ID: 12664053)
1. Do surface modifying additives (SMA) influence blood loss and thrombogenicity in conventional cardiopulmonary bypass for coronary artery bypass grafting?
Martens S; Matheis G; Wimmer-Greinecker G; Scherer M; Doss M; Moritz A
Cardiovasc Surg; 2003 Apr; 11(2):159-63. PubMed ID: 12664053
[TBL] [Abstract][Full Text] [Related]
2. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility.
Gu YJ; Boonstra PW; Rijnsburger AA; Haan J; van Oeveren W
Ann Thorac Surg; 1998 May; 65(5):1342-7. PubMed ID: 9594864
[TBL] [Abstract][Full Text] [Related]
3. Haemostasis alterations in coronary artery bypass grafting: comparison between the off-pump technique and a closed coated cardiopulmonary bypass system.
Scrascia G; Rotunno C; Guida P; Conte M; Amorese L; Margari V; Schinosa Lde L; Paparella D
Interact Cardiovasc Thorac Surg; 2013 May; 16(5):636-42. PubMed ID: 23335652
[TBL] [Abstract][Full Text] [Related]
4. Comparison of minimally invasive closed circuit extracorporeal circulation with conventional cardiopulmonary bypass and with off-pump technique in CABG patients: selected parameters of coagulation and inflammatory system.
Wippermann J; Albes JM; Hartrumpf M; Kaluza M; Vollandt R; Bruhin R; Wahlers T
Eur J Cardiothorac Surg; 2005 Jul; 28(1):127-32. PubMed ID: 15939621
[TBL] [Abstract][Full Text] [Related]
5. In vivo comparison study of FDA-approved surface-modifying additives and poly-2-methoxyethylacrylate circuit surfaces coatings during cardiopulmonary bypass.
Ask A; Holt D; Smith L
J Extra Corpor Technol; 2006 Mar; 38(1):27-32. PubMed ID: 16637520
[TBL] [Abstract][Full Text] [Related]
6. The Effects of Steroids on Coagulation Dysfunction Induced by Cardiopulmonary Bypass: A Steroids in Cardiac Surgery (SIRS) Trial Substudy.
Paparella D; Parolari A; Rotunno C; Vincent J; Myasoedova V; Guida P; De Palo M; Margari V; Devereaux PJ; Lamy A; Alamanni F; Yusuf S; Whitlock R
Semin Thorac Cardiovasc Surg; 2017 Spring; 29(1):35-44. PubMed ID: 28683994
[TBL] [Abstract][Full Text] [Related]
7. Complete heparin-coated (CBAS) cardiopulmonary bypass and reduced systemic heparin dose; effects on coagulation and fibrinolysis.
Ovrum E; Brosstad F; Am Holen E; Tangen G; Abdelnoor M; Oystese R
Eur J Cardiothorac Surg; 1996; 10(6):449-55. PubMed ID: 8817142
[TBL] [Abstract][Full Text] [Related]
8. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass.
Gorman RC; Ziats N; Rao AK; Gikakis N; Sun L; Khan MM; Stenach N; Sapatnekar S; Chouhan V; Gorman JH; Niewiarowski S; Colman RW; Anderson JM; Edmunds LH
J Thorac Cardiovasc Surg; 1996 Jan; 111(1):1-11; discussion 11-2. PubMed ID: 8551753
[TBL] [Abstract][Full Text] [Related]
9. The use of minimized extracorporeal circulation system has a beneficial effect on hemostasis--a randomized clinical study.
Abdel-Rahman U; Martens S; Risteski P; Ozaslan F; Riaz M; Moritz A; Wimmer-Greinecker G
Heart Surg Forum; 2006; 9(1):E543-8. PubMed ID: 16403712
[TBL] [Abstract][Full Text] [Related]
10. Effects on coagulation and fibrinolysis with reduced versus full systemic heparinization and heparin-coated cardiopulmonary bypass.
Ovrum E; Brosstad F; Am Holen E; Tangen G; Abdelnoor M
Circulation; 1995 Nov; 92(9):2579-84. PubMed ID: 7586360
[TBL] [Abstract][Full Text] [Related]
11. Activation of fibrinolysis in the pericardial cavity after cardiopulmonary bypass.
Khalil PN; Ismail M; Kalmar P; von Knobelsdorff G; Marx G
Thromb Haemost; 2004 Sep; 92(3):568-74. PubMed ID: 15351853
[TBL] [Abstract][Full Text] [Related]
12. Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass.
Kawasuji M; Ueyama K; Sakakibara N; Tedoriya T; Matsunaga Y; Misaki T; Watanabe Y
Ann Thorac Surg; 1993 May; 55(5):1205-9. PubMed ID: 7684219
[TBL] [Abstract][Full Text] [Related]
13. Cardiopulmonary bypass copolymer surface modification reduces neither blood loss nor transfusions in coronary artery surgery.
Südkamp M; Mehlhorn U; Reza Raji M; Hekmat K; Easo J; Geissler HJ; Sindhu D; de Vivie R
Thorac Cardiovasc Surg; 2002 Feb; 50(1):5-10. PubMed ID: 11847596
[TBL] [Abstract][Full Text] [Related]
14. The influence of acute preoperative plasmapheresis on coagulation tests, fibrinolysis, blood loss and transfusion requirements in cardiac surgery.
Menges T; Welters I; Wagner RM; Boldt J; Dapper F; Hempelmann G
Eur J Cardiothorac Surg; 1997 Mar; 11(3):557-63. PubMed ID: 9105824
[TBL] [Abstract][Full Text] [Related]
15. SMA circuits reduce platelet consumption and platelet factor release during cardiac surgery.
Defraigne JO; Pincemail J; Dekoster G; Larbuisson R; Dujardin M; Blaffart F; David JL; Limet R
Ann Thorac Surg; 2000 Dec; 70(6):2075-81. PubMed ID: 11156123
[TBL] [Abstract][Full Text] [Related]
16. Decreased blood loss after cardiopulmonary bypass using heparin-coated circuit and 50% reduction of heparin dose.
Borowiec J; Thelin S; Bagge L; Hultman J; Hansson HE
Scand J Thorac Cardiovasc Surg; 1992; 26(3):177-85. PubMed ID: 1287831
[TBL] [Abstract][Full Text] [Related]
17. Closed cardiopulmonary bypass circuits suppress thrombin generation during coronary artery bypass grafting.
Nakahira A; Sasaki Y; Hirai H; Fukui T; Matsuo M; Takahashi Y; Kotani S; Suehiro S
Interact Cardiovasc Thorac Surg; 2010 Apr; 10(4):555-60. PubMed ID: 20061337
[TBL] [Abstract][Full Text] [Related]
18. Heparin coating of extracorporeal circuits inhibits contact activation during cardiac operations.
te Velthuis H; Baufreton C; Jansen PG; Thijs CM; Hack CE; Sturk A; Wildevuur CR; Loisance DY
J Thorac Cardiovasc Surg; 1997 Jul; 114(1):117-22. PubMed ID: 9240301
[TBL] [Abstract][Full Text] [Related]
19. Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation.
Livingston ER; Fisher CA; Bibidakis EJ; Pathak AS; Todd BA; Furukawa S; McClurken JB; Addonizio VP; Jeevanandam V
Circulation; 1996 Nov; 94(9 Suppl):II227-34. PubMed ID: 8901751
[TBL] [Abstract][Full Text] [Related]
20. Completely heparinized cardiopulmonary bypass and reduced systemic heparin: clinical and hemostatic effects.
Ovrum E; Holen EA; Tangen G; Brosstad F; Abdelnoor M; Ringdal MA; Oystese R; Istad R
Ann Thorac Surg; 1995 Aug; 60(2):365-71. PubMed ID: 7646097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
